Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

Erstveröffentlichung
2018Authors
Krauter, Juergen
Fiedler, Walter
Schlenk, Richard Friedrich
Paschka, Peter
Thol, Felicitas
Wissenschaftlicher Artikel
Published in
British Journal of Haematology ; 183 (2018), 2. - S. 235-241. - ISSN 0007-1048. - eISSN 1365-2141